SetPoint Medical Investors 2026

SetPoint Medical — investors and similar companies (66)

SetPoint Medical's investor syndicate for 2026, drawn from verified round records: 18 distinct firms and angels appear on the cap table, including Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest, New Enterprise Associates (NEA). SetPoint Medical is tracked in Biotech and headquartered in Thousand Oaks, California.

The companies listed below are ranked by how much of that syndicate they share, so the overlap you see is backer-based rather than sector-based. Every investor name links to that firm's own profile with its full tracked portfolio, and every company links to its funding record.

• Verified backers on record: 18
• Total disclosed funding: $220M
• Latest tracked round: Series D (2025-08-11)
• Sector: Biotech
• Headquarters: Thousand Oaks, California

• Elevage Medical Technologies
• Ally Bridge Group
• Northwell Health
• SPRIG Equity
• Norwest
• New Enterprise Associates (NEA)
• Viking Global Investors
• Action Potential Venture Capital
• Abbott
• Boston Scientific
• Euclidean Capital
• Richard King Mellon Foundation
• Morgenthaler Ventures
• ShangBay Capital
• Ascendum Capital
• Catalio Capital Management
• Gilmartin Capital
• Midas Capital
• Hummingbird Bioscience — shares Ally Bridge Group
• Endeavor BioMedicines — shares Ally Bridge Group
• Francis Medical — shares Boston Scientific
• InSightec — shares Ally Bridge Group +2
• IsoPlexis — shares Ally Bridge Group
• Antheia — shares Viking Global Investors
• FogPharma — shares Catalio Capital Management
• Amylyx Pharmaceuticals — shares Viking Global Investors
• World Labs — shares New Enterprise Associates (NEA)
• VelosBio — shares Viking Global Investors
• OnCusp Therapeutics — shares Catalio Capital Management
• Talaris Therapeutics — shares Viking Global Investors
• GlycoEra — shares Catalio Capital Management
• Sherlock Biosciences — shares Catalio Capital Management
• Ray Therapeutics — shares Norwest
• Nuvaira — shares Richard King Mellon Foundation +1
• RayzeBio — shares Viking Global Investors
• Vida Health — shares Ally Bridge Group
• Nectero Medical — shares Boston Scientific
• Diagonal Therapeutics — shares Viking Global Investors
• LightForce — shares Ally Bridge Group
• Neumora Therapeutics — shares Catalio Capital Management
• Minerva Neuroscience — shares Ally Bridge Group
• Cartography Biosciences — shares Catalio Capital Management
• Dock — shares Viking Global Investors
• Valgen Medtech — shares Ascendum Capital
• Saluda Medical — shares Boston Scientific +1
• Galvanize Therapeutics — shares Elevage Medical Technologies +2
• Character Biosciences — shares Catalio Capital Management
• Capillary Technologies — shares Norwest
• Valsoft — shares Viking Global Investors
• DataRobot — shares New Enterprise Associates (NEA)
• Aetion — shares New Enterprise Associates (NEA)
• Preventice Solutions — shares Boston Scientific
• Mojo Vision — shares New Enterprise Associates (NEA)
• Affini-T Therapeutics — shares Catalio Capital Management
• Xilis — shares Catalio Capital Management
• Paige — shares Catalio Capital Management
• Pair Eyewear — shares New Enterprise Associates (NEA)
• Redesign Health — shares Euclidean Capital
• Callio Therapeutics — shares Norwest
• Splashtop — shares New Enterprise Associates (NEA)
• Cloudbeds — shares Viking Global Investors
• Surface Oncology — shares Catalio Capital Management
• Talkdesk — shares Viking Global Investors
• Sion Power — shares Euclidean Capital
• Mobvista — shares Midas Capital
• Dock (formerly Conductor Technology) — shares Viking Global Investors

SetPoint Medical funding profile · All research reports